Thiophosgene → HCID 20192957, compound
Reaction equation
[NH2:1][C:2]1[C:14]([N:15]2[CH2:20][CH2:19][CH2:18][CH:17]([CH3:21])[CH2:16]2)=[CH:13][C:5]2[N:6]=[C:7]([C:9]([CH3:12])([CH3:11])[CH3:10])[S:8][C:4]=2[CH:3]=1.C(=O)(O)[O-].[K+].[C:27](Cl)(Cl)=[S:28]>C(Cl)(Cl)Cl>[C:9]([C:7]1[S:8][C:4]2[CH:3]=[C:2]([N:1]=[C:27]=[S:28])[C:14]([N:15]3[CH2:20][CH2:19][CH2:18][CH:17]([CH3:21])[CH2:16]3)=[CH:13][C:5]=2[N:6]=1)([CH3:12])([CH3:11])[CH3:10]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a cooled mixture of 1.5 g of 6-amino-2-tert-butyl-5-[3-methylpiperidin-1-yl]benzothiazole and 1.5 g of potassium bicarbonate in 50 ml of chloroform is added dropwise 0.6 g of thiophosgene in 5 ml of chloroform under stirring. The stirring is continued for 30 minutes maintaining the temperature at 0°-2°. The solid is filtered and the filtrate is evaporated. The residue thus obtained is dissolved in chloroform and filtered through a silica gel column. The filtrate is evaporated to give 2-tert-butyl-6-isothiocyanato-5-[3-methylpiperidin-1-yl]benzothiazole, melting at 47°-52°.
Workup
- temperaturemaintaining the temperature at 0°-2°
- filtrationThe solid is filtered
- customthe filtrate is evaporated
- customThe residue thus obtained
- filtrationfiltered through a silica gel column
- customThe filtrate is evaporated
Sources & evidence
- ORD record
- ord-4cc25fd801834f62baca4f8c88d544bc
- Source dataset
- uspto-grants-1987_07
- Patent number
- US04680301
Reaction notes
Loading…